In the present study, we employed BRD3308, a new selective inhibitor of HDAC3, for early intervention in septic mice, observed its potential alleviating effect on ALI, and investigated the associated mechanisms, aiming to provide novel strategies for clinically preventing and treating sepsis-induced ALI. The gene discussed is HDAC3; the disease is acute respiratory distress syndrome.